Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • RnM3423194
    • |
  • 15 May, 2019
    • |
  • 75 Pages
    • |
  • GlobalData
    • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,407.14
10,814.27
16,221.41
6,512.35
13,024.69
19,537.04
1,068,066.55
2,136,133.10
3,204,199.65
590,378.00
1,180,756.00
1,771,134.00
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo